Laurion Capital Management »

Xenon Pharmaceuticals shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.7M 171k 38.99
2024-03-31 $10M 239k 43.05
2023-12-31 $3.5M 75k 46.06
2022-06-30 $304k 10k 30.40

More positions owned by Laurion Capital Management

NVIDIA Corporation Call Option (NVDA)
Advanced Micro Devices Call Option (AMD)
Meta Platforms Cl A Call Option (META)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
United States Steel Corporation (X)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Hess (HES)
Ansys (ANSS)
Discover Financial Services (DFS)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Broadcom Call Option (AVGO)
Bridgebio Pharma (BBIO)
Bank of America Corporation (BAC)

View all positions for Laurion Capital Management

Top funds holding Xenon Pharmaceuticals

Driehaus Capital Management
Braidwell
Commodore Capital
Capital World Investors
Capital Research and Management Company - Division 3
BlackRock
BlackRock
Pictet Asset Management Holding SA
T. Rowe Price Investment Management
Alliancebernstein
Rock Springs Capital Management
Marshall Wace
First Light Asset Management
Affinity Asset Advisors
Henderson Group

View all funds holding Xenon Pharmaceuticals